ENTBF News and Press, Entheon Biomedical Corp Com

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") wishes to correct the effective date of the appointment of Adam Emes as a director of the Company as stated in the Company's news releas...

Toronto, Ontario--(Newsfile Corp. - May 25, 2026) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") announces that further to its news release dated January 19, 2026, the definitive business combination agreement dated January 19, 2026, as amended o...

Toronto, Ontario--(Newsfile Corp. - January 19, 2026) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") is pleased to announce that it has entered into a definitive business combination agreement (the " Business Combination Agreement ") with Nutravi...

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") is pleased to announce that it has entered into a binding Letter of Intent (the " LOI ") dated December 18, 2025, with Nutravisor Inc...

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") announces the appointment of Harrison Newlands to the Company's Board of Directors, effective April 3, 2025. Harrison Newlands has a div...

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") announces that the Company has granted options to purchase up to an aggregate 40,000 common shares in the Company (the "Options") to cer...

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") announces that, further to its news release dated January 24, 2025, 1000141080 Ontario Ltd. (" Mentis AI ") has terminated the letter of...

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) (" Entheon " or the " Company ") is pleased to announce that it has entered into a binding letter of intent (" LOI ") dated January 23, 2025 with 1000141080 Ontario Lt...